🚀 VC round data is live in beta, check it out!
Asker Healthcare Group Valuation Multiples
Discover revenue and EBITDA valuation multiples for Asker Healthcare Group and similar public comparables like Medicover, Global Health, Dallah Healthcare, Meinian Onehealth and more.
Asker Healthcare Group Overview
About Asker Healthcare Group
Asker Healthcare Group AB is a provider of medical products and solutions that drive progress in the European healthcare sector. The company is engaged in building and acquiring companies to support the healthcare system to improve patient outcomes, reduce the total cost of care, and ensure a fair and sustainable value chain. The company also offers a range of value-added solutions to support its suppliers and customers in, for example, market access, efficiency, and sustainability.
Founded
2006
HQ
Employees
4.0K
Website
Sectors
Financials (LTM)
EV
$4B
Asker Healthcare Group Financials
Asker Healthcare Group reported last 12-month revenue of $2B and EBITDA of $236M.
In the same LTM period, Asker Healthcare Group generated $749M in gross profit, $236M in EBITDA, and $73M in net income.
Revenue (LTM)
Asker Healthcare Group P&L
In the most recent fiscal year, Asker Healthcare Group reported revenue of $2B and EBITDA of $227M.
Asker Healthcare Group expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $2B | XXX | $2B | XXX | XXX | XXX |
| Gross Profit | $749M | XXX | $748M | XXX | XXX | XXX |
| Gross Margin | 38% | XXX | 40% | XXX | XXX | XXX |
| EBITDA | $236M | XXX | $227M | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBIT Margin | 8% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | $73M | XXX | $65M | XXX | XXX | XXX |
| Net Margin | 4% | XXX | 3% | XXX | XXX | XXX |
| Net Debt | — | — | $424M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Asker Healthcare Group Stock Performance
Asker Healthcare Group has current market cap of $3B, and enterprise value of $4B.
Market Cap Evolution
Asker Healthcare Group's stock price is $8.50.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $4B | $3B | 0.4% | XXX | XXX | XXX | $0.17 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAsker Healthcare Group Valuation Multiples
Asker Healthcare Group trades at 1.9x EV/Revenue multiple, and 16.1x EV/EBITDA.
EV / Revenue (LTM)
Asker Healthcare Group Financial Valuation Multiples
As of April 18, 2026, Asker Healthcare Group has market cap of $3B and EV of $4B.
Equity research analysts estimate Asker Healthcare Group's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Asker Healthcare Group has a P/E ratio of 44.9x.
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $3B | XXX | $3B | XXX | XXX | XXX |
| EV (current) | $4B | XXX | $4B | XXX | XXX | XXX |
| EV/Revenue | 1.9x | XXX | 2.0x | XXX | XXX | XXX |
| EV/EBITDA | 16.1x | XXX | 16.7x | XXX | XXX | XXX |
| EV/EBIT | 25.3x | XXX | 26.6x | XXX | XXX | XXX |
| EV/Gross Profit | 5.1x | XXX | 5.1x | XXX | XXX | XXX |
| P/E | 44.9x | XXX | 50.3x | XXX | XXX | XXX |
| EV/FCF | 56.3x | XXX | 47.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Asker Healthcare Group Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Asker Healthcare Group Margins & Growth Rates
Asker Healthcare Group's revenue in the last 12 month grew by 9%.
Asker Healthcare Group's revenue per employee in the last FY averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Asker Healthcare Group's rule of 40 is 26% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Asker Healthcare Group's rule of X is 47% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Asker Healthcare Group Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | 10% | XXX | XXX | XXX |
| EBITDA Margin | 12% | XXX | 12% | XXX | XXX | XXX |
| EBITDA Growth | 12% | XXX | 13% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | 26% | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | 47% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.5M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 24% | XXX | 25% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 10% | XXX | 10% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 34% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Asker Healthcare Group Public Comps
See public comps and valuation multiples for other Hospitals & Clinics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Asker Healthcare Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Medicover | XXX | XXX | XXX | XXX | XXX | XXX |
| Global Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Dallah Healthcare | XXX | XXX | XXX | XXX | XXX | XXX |
| Meinian Onehealth | XXX | XXX | XXX | XXX | XXX | XXX |
| Concentra Group | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Asker Healthcare Group M&A Activity
Asker Healthcare Group acquired XXX companies to date.
Last acquisition by Asker Healthcare Group was on XXXXXXXX, XXXXX. Asker Healthcare Group acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Asker Healthcare Group
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAsker Healthcare Group Investment Activity
Asker Healthcare Group invested in XXX companies to date.
Asker Healthcare Group made its latest investment on XXXXXXXX, XXXXX. Asker Healthcare Group invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Asker Healthcare Group
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Asker Healthcare Group
| When was Asker Healthcare Group founded? | Asker Healthcare Group was founded in 2006. |
| Where is Asker Healthcare Group headquartered? | Asker Healthcare Group is headquartered in Sweden. |
| How many employees does Asker Healthcare Group have? | As of today, Asker Healthcare Group has over 4K employees. |
| Who is the CEO of Asker Healthcare Group? | Asker Healthcare Group's CEO is Johan Falk. |
| Is Asker Healthcare Group publicly listed? | Yes, Asker Healthcare Group is a public company listed on Nasdaq Stockholm. |
| What is the stock symbol of Asker Healthcare Group? | Asker Healthcare Group trades under ASKER ticker. |
| When did Asker Healthcare Group go public? | Asker Healthcare Group went public in 2025. |
| Who are competitors of Asker Healthcare Group? | Asker Healthcare Group main competitors are Medicover, Global Health, Dallah Healthcare, Meinian Onehealth. |
| What is the current market cap of Asker Healthcare Group? | Asker Healthcare Group's current market cap is $3B. |
| What is the current revenue of Asker Healthcare Group? | Asker Healthcare Group's last 12 months revenue is $2B. |
| What is the current revenue growth of Asker Healthcare Group? | Asker Healthcare Group revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Asker Healthcare Group? | Current revenue multiple of Asker Healthcare Group is 1.9x. |
| Is Asker Healthcare Group profitable? | Yes, Asker Healthcare Group is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Asker Healthcare Group? | Asker Healthcare Group's last 12 months EBITDA is $236M. |
| What is Asker Healthcare Group's EBITDA margin? | Asker Healthcare Group's last 12 months EBITDA margin is 12%. |
| What is the current EV/EBITDA multiple of Asker Healthcare Group? | Current EBITDA multiple of Asker Healthcare Group is 16.1x. |
| What is the current FCF of Asker Healthcare Group? | Asker Healthcare Group's last 12 months FCF is $67M. |
| What is Asker Healthcare Group's FCF margin? | Asker Healthcare Group's last 12 months FCF margin is 3%. |
| What is the current EV/FCF multiple of Asker Healthcare Group? | Current FCF multiple of Asker Healthcare Group is 56.3x. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.